Surgery Partners Statistics
Want to see SGRY full AI Analyst Report?
Surgery Partners (SGRY) Stock Statistics & Valuation Metrics
Total Valuation
Surgery Partners has a market cap or net worth of $2.99B. The enterprise value is $7.80B.
- Market Cap
- $2.99B
- Enterprise Value
- $7.80B
Share Statistics
Surgery Partners has 128,874,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 128,874,800
- Owned by Insiders
- 1.67%
- Owned by Institutions
- 41.95%
Financial Efficiency
Surgery Partners’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is 4.24%.
- Return on Equity (ROE)
- -0.05
- Return on Assets (ROA)
- -0.01
- Return on Invested Capital (ROIC)
- 4.24%
- Return on Capital Employed (ROCE)
- 0.05
- Revenue Per Employee
- 206.79K
- Profits Per Employee
- -4,868.75
- Employee Count
- 16,000
- Asset Turnover
- 0.40
- Inventory Turnover
- 26.33
Valuation Ratios
The current PE Ratio of Surgery Partners is -39.48. Surgery Partners’s PEG ratio is -1.07.
- PE Ratio
- -39.48
- PS Ratio
- 1.01
- PB Ratio
- 2.05
- Price to FCF
- 120.45
- Price to Operating Cash Flow
- 32.96
- PEG Ratio
- -1.07
Income Statement
In the last 12 months, Surgery Partners had revenue of 3.31B and earned -77.90M in profits. Earnings per share was -0.61.
- Revenue
- 3.31B
- Gross Profit
- 765.00M
- Operating Income
- 389.50M
- Pretax Income
- 116.90M
- Net Income
- -77.90M
- EBITDA
- 565.50M
- Earnings Per Share (EPS)
- -0.61
Cash Flow
In the last 12 months, operating cash flow was 277.90M and capital expenditures -75.10M, giving a free cash flow of 202.80M billion.
- Operating Cash Flow
- 277.90M
- Free Cash Flow
- 202.80M
- Free Cash Flow per Share
- 0.22
Dividends & Yields
Surgery Partners pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 5.50%
- Earnings Yield
- -2.60%
Stock Price Statistics
- Beta
- 1.05
- 52-Week Price Change
- 7.36%
- 50-Day Moving Average
- 16.05
- 200-Day Moving Average
- 14.79
- Relative Strength Index (RSI)
- 85.40
- Average Volume (3m)
- 3.63M
Important Dates
Surgery Partners upcoming earnings date is Nov 10, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Nov 10, 2026
- Next Earnings Date
- Nov 10, 2026
- Ex-Dividend Date
- ―
Financial Position
Surgery Partners as a current ratio of 1.87, with Debt / Equity ratio of 234.97%
- Current Ratio
- 1.87
- Quick Ratio
- 1.71
- Debt to Market Cap
- 1.43
- Net Debt to EBITDA
- 6.69
- Interest Coverage Ratio
- 1.43
Taxes
In the past 12 months, Surgery Partners has paid 18.00M in taxes.
- Income Tax
- 18.00M
- Effective Tax Rate
- 0.15
Enterprise Valuation
Surgery Partners EV to EBITDA ratio is 7.61, with an EV/FCF ratio of 38.43.
- EV to Sales
- 2.14
- EV to EBITDA
- 7.61
- EV to Free Cash Flow
- 38.43
- EV to Operating Cash Flow
- 27.94
Balance Sheet
Surgery Partners has $354.50M in cash and marketable securities with $3.31B in debt, giving a net cash position of -$2.96B billion.
- Cash & Marketable Securities
- $354.50M
- Total Debt
- $3.31B
- Net Cash
- -$2.96B
- Net Cash Per Share
- -$22.95
- Tangible Book Value Per Share
- -$10.76
Margins
Gross margin is 21.10%, with operating margin of 11.32%, and net profit margin of -2.59%.
- Gross Margin
- 21.10%
- Operating Margin
- 11.32%
- Pretax Margin
- 2.66%
- Net Profit Margin
- -2.59%
- EBITDA Margin
- 14.56%
- EBIT Margin
- 12.04%
Analyst Forecast
The average price target for Surgery Partners is $21.06, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- $21.06
- Price Target Upside
- 9.21% Downside
- Analyst Consensus
- Neutral
- Analyst Count
- 9
- Revenue Growth Forecast
- 3.99%
- EPS Growth Forecast
- 51.58%
Scores
- Smart Score
- 1
- AI Score
- 54
